| 000 | 01126 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511183227.0 | ||
| 264 | 0 | _c19921026 | |
| 008 | 199210s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalvert, A H | |
| 245 | 0 | 0 |
_aFuture directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin? _h[electronic resource] |
| 260 |
_bSeminars in oncology _cFeb 1992 |
||
| 300 |
_a155-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHematopoietic Cell Growth Factors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aNewell, D R | |
| 700 | 1 | _aGore, M E | |
| 773 | 0 |
_tSeminars in oncology _gvol. 19 _gno. 1 Suppl 2 _gp. 155-63 |
|
| 999 |
_c1418118 _d1418118 |
||